Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Peripheral Helper Cells May Provide Clue to RA Pathology

Lara C. Pullen, PhD  |  February 27, 2017

Patients with rheumatoid arthritis (RA) possess an immune system that attacks the joints, causing inflammation, pain and, eventually, tissue destruction. RA can be either seropositive or seronegative, with seropositive RA patients often presenting with more severe symptoms. Although rheumatologists assume pathological cellular immune responses occur in patients with seropositive RA, they have, until now, lacked a cellular marker that distinguishes between seropositive and seronegative populations.

This month, Deepak A. Rao, MD, PhD, co-director of the Human Immunology Center at Brigham and Women’s Hospital (BWH) in Boston, and colleagues published their description of a newly identified subset of T cells, named peripheral helper (TPH) cells. These cells appear to work within the inflamed non-lymphoid tissues of patients with seropositive RA to promote pathological B cell responses and antibody production. The investigators used mass cytometry and RNA sequencing to perform a detailed analysis of this small population of cells found in the synovium of patients with seropositive RA. They published their results in the Feb. 2 issue of Nature.¹

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Their transcriptome analysis revealed a population of PD-1hiCXCR5–CD4+ T cells (TPH) that had expanded in the joints of patients with seropositive RA. PD-1 is well known as an inhibitory receptor; although these cells expressed high levels of PD-1, they are not exhausted. Rather, the cells expressed factors that enable B cell help, including IL-21, CXCL13, ICOS and MAF.

“We’ve known for a long time that T cells and B cells infiltrate the synovium and contribute to inflammation in the joint,” explains Dr. Rao in an email to The Rheumatologist. “This study identifies a large population of T cells in the synovium that appears to drive the B cell response in the joint. Discovery of this population may allow us to develop new therapies that specifically target this pathologic T cell population, while sparing other protective T cells.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

TPH Cells in the Synovium
The TPH cells represent approximately one-quarter of the helper T cells found in RA joints. The researchers explain that the TPH cells are similar to PD-1hiCXCR5+ T follicular helper cells in that they induce plasma cell differentiation in vitro via IL-21 excretion and SLAMF5 interaction. A closer analysis of the transcriptome of the novel TPH population revealed, however, that TPH and T follicular helper cells differ in expression of BCL6 and BLIMP1.

“There’s a general sense among rheumatologists that seropositive RA behaves differently from seronegative RA,” elaborates Dr. Rao. “The specific enrichment of TPH cells in seropositive RA samples and not other inflammatory arthritides (i.e., seronegative RA, psoriatic arthritis, juvenile arthritis) is really striking.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:B cellsperipheral helper cellsRheumatoid Arthritis (RA)seropositive RAT cell

Related Articles

    Rheumatology Research Foundation Funding Enables Potential Treatment Advancements

    June 13, 2017

    Investigators at Brigham and Women’s Hospital recently discovered a novel subset of peripheral helper T cells (TPH) that drive rheumatoid arthritis (RA) inflammation. Originally published in the February issue of Nature, findings from this study provided bedrock knowledge for developing new RA therapies. Now, with funding from the Rheumatology Research Foundation, investigators are expanding on…

    Foot Pain a Burden for Rheumatology Patients

    January 13, 2012

    Researchers say it may even correlate with back, hip, and knee pain

    Th 17 Cells and Arthritis

    July 1, 2008

    The true story of how IL-17 became a focus for RA research

    FOCIS 2015: TET Protein Regulation May Provide Insights for Cancer Treatment

    September 15, 2015

    A presentation given during FOCIS 2015, the 15th annual meeting of the Federation of Clinical Immunity Societies in June 2015 in San Diego, focused on advances in stem cell research related to treatment of cancer and the function that particular enzymes play in disease. Anjana Rao, PhD, professor at the La Jolla Institute for Allergy…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences